Cabaletta Bio, Inc. (CABA)
$1.62-4.14%Close
SELLCRISIS · day 26
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $264M
- Beta
- 3.48
- P/E (TTM)
- -1.03
- Short % float
- 27.02%
- Days to cover
- 6.3
- SI change
- +15.9%
- 1W
- -17.77%
- 1M
- -37.69%
- vs SPY 1W
- -17.63%
- vs SPY 1M
- -40.20%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CABA?
- LOPJLB’s latest quantitative signal on Cabaletta Bio, Inc. (CABA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CABA in?
- Cabaletta Bio, Inc. (CABA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Cabaletta Bio, Inc. (CABA) do?
- Cabaletta Bio, Inc. is a biotechnology firm in the clinical development stage, specializing in the invention and advancement of sophisticated engineered T cell therapies. Its core mission is to treat autoimmune diseases where B cells are implicated in producing harmful autoantibodies. The company's unique chimeric autoantibody receptor (CAAR) T cell platform is engineered to precisely target an…